| Phase 4 |
| NCT07307235 |
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China… |
Type 2 Diabetes |
Recruiting |
2026-07-07 |
| NCT07172451 |
Gelaspan vs Crystalloid Therapy in Sepsis |
Sepsis |
Recruiting |
2026-03-20 |
| NCT06451198 |
IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly… |
Coronary Artery Disease |
Recruiting |
2026-03-12 |
| NCT07272512 |
Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced… |
Neuroendocrine Tumors |
Recruiting |
2025-12-19 |
| NCT06725810 |
Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease |
Chronic Kidney Disease Associated Anemia |
Recruiting |
2025-07-28 |
| NCT06498089 |
A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy… |
Takayasu Arteritis |
Recruiting |
2024-10-17 |
| NCT05102448 |
Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis |
Takayasu Arteritis |
Recruiting |
2024-10-15 |
| NCT04300686 |
A Pilot Study in Severe Patients With Takayasu Arteritis. |
Takayasu Arteritis |
Recruiting |
2021-08-10 |
| NCT07815106 |
OPtimization of Antiplatelet Therapy After the intervenTION of de Novo Coronary Artery… |
Chronic Coronary Syndrome |
Not Yet Recruiting |
2026-09-11 |
| NCT07621380 |
Ertugliflozin's Effect on Heart Function in Diabetic Patients After Myocardial Infarction |
Type 2 Diabetes Mellitus Myocardial Infarction |
Not Yet Recruiting |
2026-06-24 |
| NCT07405684 |
Fecal Molecular Susceptibility-guided Hp First-line Therapy |
HELICOBACTER PYLORI INFECTIONS |
Not Yet Recruiting |
2026-02-12 |
| NCT07405697 |
Fecal Molecular Susceptibility-guided Hp Rescue Therapy |
Helicobacter Pylori Infection |
Not Yet Recruiting |
2026-02-12 |
| NCT07325357 |
Effect of Pirfenidone on TA Fibrosis |
Takayasu Arteritis |
Not Yet Recruiting |
2026-01-08 |
| NCT07156656 |
Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection |
Type A Aortic Dissection |
Not Yet Recruiting |
2025-09-05 |
| NCT06863363 |
PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults |
Non-diabetic Obesity |
Not Yet Recruiting |
2025-03-07 |
| Phase 3 |
| NCT07320625 |
Efficacy of Montelukast on STEMl Patients |
Myocardial Infarction (MI) |
Recruiting |
2026-01-13 |
| NCT07309289 |
NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line… |
Metastatic Colorectal Cancer (CRC) |
Recruiting |
2025-12-30 |
| NCT07725484 |
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients |
Heart Failure Due to Coronary Artery Disease |
Not Yet Recruiting |
2026-08-05 |
| NCT07508956 |
Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant… |
Gastric / Gastroesophageal Junction Adenocarcinoma |
Not Yet Recruiting |
2026-06-08 |
| NCT07479784 |
Octreotide Microspheres for Preventing Pancreatic Fistula |
Pancreatic Fistula |
Not Yet Recruiting |
2026-03-18 |
| NCT07231523 |
EFG vs IVIG in TAMG |
Efgartigimod |
Not Yet Recruiting |
2025-11-17 |
| Phase 2/3 |
| NCT06796803 |
Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC)… |
Potentially Resectable Hepatocellular Carcinoma |
Recruiting |
2026-07-17 |
| NCT04973306 |
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable… |
Esophageal Squamous Cell Carcinoma Stage II |
Recruiting |
2022-06-30 |
| NCT07309419 |
A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus… |
Hepatocellular Carcinoma |
Not Yet Recruiting |
2025-12-30 |
| NCT04669496 |
Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX… |
Intrahepatic Cholangiocarcinoma |
Active, Not Recruiting |
2025-09-04 |